Business - Briefly   

Lupin bags USFDA approval

MUMBAI: Lupin announced that the U.S. Food and Drug Administration (USFDA) has approved the company's Abbreviated New Drug Application (ANDA) for Cefotaxime vials for injection 500 mg, 1g and 2g, the generic equivalent of Claforan marketed by Abbott Laboratories, Inc. "This is the second ANDA approval for Lupin in this quarter. Lupin received FDA approval for Cefuroxime Axetil tablets in July 2003,'' stated a press release issued here today by Lupin. — Our Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• RBI to evaluate new framework
• Efforts on to help tea industry
• Max India to sell stake in Max HealthScribe
• SAIL hopes to improve performance
• Tardy progress in oil sector reform
• Mild rally in rupee
• Sensex up 85 points
• Centre clarifies on textiles package
• AMD unveils Athlon 64 processors
• Lax network security curbing e-commerce
• West Bengal announces IT policy
• Futures trading in gold and silver
• Exchange rates
• Bullion rates
• Stock Market Index
• CII logistics summit
• Taj Palace Dubai gets good occupancy rate
• Lupin bags USFDA approval
• Promoters raise stake in D-Link
• GNFC's achievement

Copyright © 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu